Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.17
Delayed Data
As of Jul 01
 -0.17 / -0.39%
Today’s Change
36.71
Today|||52-Week Range
44.85
+8.52%
Year-to-Date
European Stocks: What's Your Pain Tolerance?
Jul 01 / TheStreet.com - Paid Partner Content
Shire and Glaxo Offer Prescription to London's Woes
Jun 28 / TheStreet.com - Paid Partner Content
Better Buy: GlaxoSmithKline plc vs. Merck
Jul 01 / MotleyFool.com - Paid Partner Content
Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals
Jun 28 / MotleyFool.com - Paid Partner Content
'Shark Tank's' Kevin O'Leary Finds 'The Opportunity of a Lifetime'
Jun 30 / TheStreet.com - Paid Partner Content
Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?
Jun 27 / MotleyFool.com - Paid Partner Content
These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains
Jun 29 / MotleyFool.com - Paid Partner Content
Mylan Launches Generic Version of Glaxo's Avodart in U.S.
Jun 27 / Zacks.com - Paid Partner Content
New Stock Research Reports for June 28, 2016
Jun 28 / Zacks.com - Paid Partner Content
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.34
Today’s open42.79
Day’s range42.71 - 43.22
Volume3,181,793
Average volume (3 months)3,491,359
Market cap$105.6B
Dividend yield5.41%
Data as of 4:02pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+15.38%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)-3.66%
P/E ratio184.5
Price/Sales2.70
Price/Book13.91

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.49+0.91%
SNYSanofi-0.06-0.14%
ABBVAbbVie+0.80+1.29%
AGNAllergan+2.93+1.27%
Data as of 4:02pm ET, 07/01/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.59
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs